Corrigendum

No authors listed

Published Erratum

No authors listed. HIV Med. 2019 Aug.

. 2019 Aug;20(7):496-499.

doi: 10.1111/hiv.12786.

No abstract available

Erratum for

Total and unbound darunavir pharmacokinetics in pregnant women infected with HIV-1: results of a study of darunavir/ritonavir 600/100 mg administered twice daily.
Zorrilla CD, Wright R, Osiyemi OO, Yasin S, Baugh B, Brown K, Coate B, Verboven P, Mrus J, Falcon R, Kakuda TN. Zorrilla CD, et al. HIV Med. 2014 Jan;15(1):50-6. doi: 10.1111/hiv.12047. Epub 2013 Jun 3. HIV Med. 2014. PMID: 23731450 Free PMC article. Clinical Trial.
Pharmacokinetics of once-daily darunavir/ritonavir in HIV-1-infected pregnant women.
Crauwels HM, Kakuda TN, Ryan B, Zorrilla C, Osiyemi OO, Yasin S, Brown K, Verboven P, Hillewaert V, Baugh B. Crauwels HM, et al. HIV Med. 2016 Oct;17(9):643-52. doi: 10.1111/hiv.12366. Epub 2016 May 17. HIV Med. 2016. PMID: 27187894 Clinical Trial.

1. Crauwels HM, Kakuda TN, Ryan B, Zorilla C, et al. Pharmacokinetics of once‐daily darunavir/ritonavir in HIV‐1–infected pregnant women. HIV Med 2016; 17 (9): 643–652. - PubMed
1. Zorrilla CD, Wright R, Osiyemi OO, Yasin S, et al. Total and unbound darunavir pharmacokinetics in pregnant women infected with HIV‐1: results of a study of darunavir/ritonavir 600/100 mg administered twice daily. HIV Med 2014; 15 (1): 50–56. - PMC - PubMed